Skip to content
Application 125486
- Type
- BLA
- Sponsor
- GENENTECH
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | GAZYVA | OBINUTUZUMAB | INJECTABLE;INJECTION | 1000MG/40ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 50242-070 | Gazyva | obinutuzumab | Genentech, Inc. | BLA | Current |
| 50242-070 | Gazyva | obinutuzumab | Genentech, Inc. | BLA | Current |
| 50242-070 | Gazyva | obinutuzumab | Genentech, Inc. | BLA | Current |
| 50242-070 | Gazyva | obinutuzumab | Genentech, Inc. | BLA | Current |
| 50242-070 | Gazyva | obinutuzumab | Genentech, Inc. | BLA | Current |
| 50242-070 | Gazyva | obinutuzumab | Genentech, Inc. | BLA | Current |
| 50242-070 | Gazyva | obinutuzumab | Genentech, Inc. | BLA | Current |